View Author
scopus: 7103389067

Holzer, H.

(Herwig Holzer)


patient mpa-auc 0 –12 rejection transplantation mpa-auc –12 hoffmann-la roche ltd incidence day 3 study mycophenolate mofetil month exposure concentration mpa exposure analysis mofetil mycophenolate difference population fdcc study rejection incidence department roche transplant hoffmann-la tacrolimu gelder mpa concentrations relationship mpaauc 0 –12 mycophenolic mpa plasma concentrations fixed-dose table antibody group center kidney mycophenolic acid patient populations transplant patients nephrology drug monitoring kidney transplantation university risk ” honoraria randomized trial therapy jean paul soulillou graft fixed-dose patients research grants tacrolimus-treated patients hospital lecture fees bristol-myers squibb proportion result cyclosporine dose adjustments mycophenolic acid exposure transplant recipients graft function concentration-effect relationship randomized trial grant monitoring wyeth mpaauc pharmacokinetic netherland silva number tacrolimus-treated novarti research fijter




1 Most Recent Publications

Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid (Article)
Gelder, T. van Tedesco-Silva, H. Holzer, H. Rostaing, L. Mamelok, R. Fijter, J.W. de Budde, K. Kuypers, D. Arns, W. Paul Soulillou, J. Kanellis, J. Zelvys, A. Ekberg, H.
2010-03-01